Literature DB >> 12706294

A method to increase the number of growth hormone receptors at the surface of cells.

Peter van Kerkhof1, Erica Vallon, Ger J Strous.   

Abstract

The number of growth hormone receptors (GHRs) per cell are regulated and this feature plays a major role in the hormone responsiveness of the body. We previously observed in transfected Chinese hamster lung cells that GHR availability is determined by three factors: endocytosis (75%), shedding (10%), and other undetermined mechanisms (15%). The endocytosis depends on an active ubiquitin conjugation system. In addition, this process is ligand-independent. Here, we show that this principle is useful to increase the abundance of GHRs at the cell surface of cells using a combination of inhibitors. In theory, an inhibitor that targets the ubiquitin conjugation specific for the GHR, would suffice, as almost 80% of the removal rate depends on this mechanism. As the molecular mechanism is unknown yet, we used a general inhibitor of proteasome action. Unfortunately, such an inhibitor stimulates the shedding process severalfold. Our data show that the combination of a general proteasome inhibitor and a matrix metalloprotease inhibitor results in an almost twofold increase in functional GHRs at the cell surface, and generate new perspectives to increase the sensitivity of cells for growth hormone.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12706294     DOI: 10.1016/s0303-7207(02)00434-3

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  3 in total

1.  βTrCP controls GH receptor degradation via two different motifs.

Authors:  Ana C da Silva Almeida; Ger J Strous; Agnes G S H van Rossum
Journal:  Mol Endocrinol       Date:  2011-10-27

2.  The growth hormone receptor interacts with its sheddase, the tumour necrosis factor-alpha-converting enzyme (TACE).

Authors:  Julia A Schantl; Marcel Roza; Peter Van Kerkhof; Ger J Strous
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

3.  MG132 proteasome inhibitor modulates proinflammatory cytokines production and expression of their receptors in U937 cells: involvement of nuclear factor-kappaB and activator protein-1.

Authors:  Pablo C Ortiz-Lazareno; Georgina Hernandez-Flores; Jorge R Dominguez-Rodriguez; Jose M Lerma-Diaz; Luis F Jave-Suarez; Adriana Aguilar-Lemarroy; Piedad C Gomez-Contreras; Daniel Scott-Algara; Alejandro Bravo-Cuellar
Journal:  Immunology       Date:  2008-02-20       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.